Skip to search.
 TSX Up 0.11% TSX Ventures Down 0.30%

Celgene Corporation (CELG)

-NasdaqGS
114.01 Down 0.19(0.17%) 4:00PM EDT
|After Hours : 114.25 Up 0.24 (0.21%) 5:14PM EDT
Prev Close:114.20
Open:114.49
Bid:113.81 x 200
Ask:114.25 x 200
1y Target Est:137.39
Beta:1.4589
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:113.92 - 115.52
52wk Range:93.05 - 128.39
Volume:2,303,075
Avg Vol (3m):4,484,840
Market Cap:88.37B
P/E (ttm):48.19
EPS (ttm):2.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGDown 0.17%88.37B
JNJUp 0.26%326.77B

Key Statistics

Forward P/E (1 yr):16.31
P/S (ttm):8.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :5.70
Quarterly EPS Est (Sep-16) :1.48
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):0.92

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell ly... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback